VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
GALT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
GALTGalectin Therapeutics Inc.
$2.98$196M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksGALTQuarterly Financials

Galectin Therapeutics Inc. (GALT) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Galectin Therapeutics Inc. (GALT) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

GALT Income Statement

Quarterly statement

GALT Income Statement

Galectin Therapeutics Inc. (GALT) annual income statement — 26-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses3.37M3.98M4.08M3.37M4.2M4.63M7.9M12.43M9.07M11.29M9.65M9.56M9.17M9M10.34M10.63M8.12M9.66M9.94M7.42M
OpEx % of Revenue--------------------
Selling, General & Admin1.8M1.85M1.85M1.43M1.59M1.36M1.41M1.32M1.47M1.48M1.59M1.33M1.43M1.63M1.54M1.63M1.52M1.59M1.88M1.57M
SG&A % of Revenue--------------------
Research & Development1.56M2.13M2.23M1.93M2.61M3.26M6.49M11.11M7.59M9.81M8.05M8.23M7.73M7.37M8.8M9.01M6.6M8.07M8.06M5.86M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income0-3.98M-4.08M-3.37M-4.2M-4.63M-7.9M-12.43M-9.07M-11.29M-9.65M-9.56M-9.17M-9M-10.34M-10.63M-8.12M-9.66M-9.94M-7.42M
Operating Margin %--------------------
Operating Income Growth %100%13.9%48.37%72.92%53.7%59.04%18.15%-29.99%1.09%-25.41%6.71%10.08%-12.85%6.82%-4.1%-43.21%1.48%-17.93%-57.27%5.2%
EBITDA0-3.98M-4.07M-3.32M-6.36M-4.62M-7.89M-12.42M-9.06M-11.28M-9.64M-9.55M-9.16M-8.46M-10.31M-10.63M-8.12M-9.65M-9.93M-7.41M
EBITDA Margin %--------------------
EBITDA Growth %100%13.95%48.46%73.23%29.73%59.02%18.18%-30%1.1%-33.29%6.51%10.1%-12.85%12.34%-3.88%-43.31%1.45%-17.99%-57.36%5.23%
D&A (Non-Cash Add-back)04K12K41K02K10K10K9K9K9K9K8K032K8K7K7K10K11K
EBIT0-827K-3.06M-3.56M-6.36M-5.7M-7.89M-10.24M-9.73M-11.1M-10.44M-9.15M-9.59M-8.46M-11.07M-10.33M-8.33M-9.38M-9.71M-6.95M
Net Interest Income0-1.98M-1.95M-1.91M-1.78M-1.8M-1.71M-1.64M-1.4M-1.19M-972K-773K-773K-600K-416K-278K-251K-226K-226K-272K
Interest Income28K28K36K26K39K26K35K84K93K80K80K74K62K50K44K30K18K3K1K0
Interest Expense-786K2M1.99M1.94M1.82M1.83M1.74M1.73M1.49M1.27M1.05M847K835K650K460K308K269K229K227K272K
Other Income/Expense0-5.13M-969K-2.13M-3.99M-2.9M-1.73M461K-2.15M-1.08M-1.84M-436K-1.26M-111K-1.19M-1K-475K49K3K204K
Pretax Income-3.53M-9.11M-5.05M-5.5M-8.18M-7.52M-9.63M-11.97M-11.22M-12.37M-11.49M-10M-10.43M-9.11M-11.53M-10.63M-8.6M-9.61M-9.93M-7.22M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-3.53M-9.11M-5.05M-5.5M-8.18M-7.52M-9.63M-11.97M-11.22M-12.37M-11.49M-10M-10.43M-9.11M-11.53M-10.63M-8.6M-9.61M-9.93M-7.22M
Net Margin %--------------------
Net Income Growth %56.85%-21.17%47.61%54.04%27.06%39.2%16.17%-19.71%-7.59%-35.74%0.33%5.99%-21.3%5.19%-16.06%-47.26%-0.9%-13.78%-56.71%8.04%
Net Income (Continuing)-3.53M-9.11M-5.05M-5.5M-8.18M-7.52M-9.63M-11.97M-11.22M-12.37M-11.49M-10M-10.43M-9.11M-11.53M-10.63M-8.6M-9.61M-9.93M-7.22M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.04-0.14-0.08-0.08-0.13-0.12-0.15-0.19-0.18-0.20-0.19-0.16-0.24-0.15-0.19-0.51-0.14-0.16-0.17-0.12
EPS Growth %69.23%-16.67%48.67%57.89%27.78%40%21.05%-18.75%25%-33.33%0%68.63%-71.43%6.25%-11.76%-325%0%-6.67%-54.55%14.29%
EPS (Basic)-0.04-0.14-0.08-0.08-0.13-0.12-0.15-0.19-0.18-0.20-0.19-0.16-0.24-0.15-0.19-0.51-0.14-0.16-0.17-0.12
Diluted Shares Outstanding89.62M65.88M65.78M63.9M64.2M63.45M63.2M62.74M62.28M62.23M61.98M60.16M59.7M59.58M59.48M59.43M59.4M59.39M59.35M58.53M
Basic Shares Outstanding89.62M65.88M65.78M63.9M64.2M63.45M63.2M62.74M62.28M62.23M61.98M60.16M59.7M59.58M59.48M59.43M59.4M59.39M59.35M58.53M
Dividend Payout Ratio--------------------